Biblio

Export 1181 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
R. L. Cowan, Beach, P. A., Atalla, S. W., Dietrich, M. S., Bruehl, S. P., Deng, J., Wang, J., Newhouse, P. A., Gore, J. C., and Monroe, T. B., “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
R. L. Cowan, Beach, P. A., Atalla, S. W., Dietrich, M. S., Bruehl, S. P., Deng, J., Wang, J., Newhouse, P. A., Gore, J. C., and Monroe, T. B., “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
C. K. Barha, Hsiung, G. - Y. R., Best, J. R., Davis, J. C., Eng, J. J., Jacova, C., Lee, P. E., Munkacsy, M., Cheung, W., and Liu-Ambrose, T., “Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1397-1410, 2017.
M. Defrancesco, Marksteiner, J., Kemmler, G., Fleischhacker, W. Wolfgang, Blasko, I., and Deisenhammer, E. A., “Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1439-1448, 2017.
M. Defrancesco, Marksteiner, J., Kemmler, G., Fleischhacker, W. Wolfgang, Blasko, I., and Deisenhammer, E. A., “Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1439-1448, 2017.
J. Yuan, Maserejian, N., Liu, Y., Devine, S., Gillis, C., Massaro, J., and Au, R., “Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
L. - L. Li, Ma, Y. - H., Bi, Y. - L., Sun, F. - R., Hu, H., Hou, X. - H., Xu, W., Shen, X. - N., Dong, Q., Tan, L., Yang, J. - L., and Yu, J. - T., “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
K. Amy Lin, Rundel, C., and P Doraiswamy, M., “Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1123-1130, 2017.
J. A. Zegarra-Valdivia, Santi, A., de Sevilla, M. Estrella F., Nuñez, A., and Aleman, I. Torres, “Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities.”, J Alzheimers Dis, vol. 69, no. 4, pp. 979-987, 2019.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., “Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.”, J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
M. Javad Hajipour, Ghasemi, F., Aghaverdi, H., Raoufi, M., Linne, U., Atyabi, F., Nabipour, I., Azhdarzadeh, M., Derakhshankhah, H., Lotfabadi, A., Bargahi, A., Alekhamis, Z., Aghaie, A., Hashemi, E., Tafakhori, A., Aghamollaii, V., Mashhadi, M. Maserat, Sheibani, S., Vali, H., and Mahmoudi, M., “Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1187-1202, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
C. LoBue, Denney, D., Hynan, L. S., Rossetti, H. C., Lacritz, L. H., Hart, J., Womack, K. B., Woon, F. L., and C Cullum, M., “Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
R. H. L. H. Rueli, Torres, D. J., Dewing, A. S. T., Kiyohara, A. C., Barayuga, S. M., Bellinger, M. T., Uyehara-Lock, J. H., White, L. R., Moreira, P. I., Berry, M. J., Perry, G., and Bellinger, F. P., “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
R. M. Wood, Garcia, Z., Daniels, N., Landon, S. M., Humayun, S., Lee, H. -gon, and Macpherson, L. J., “Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”, J Alzheimers Dis, 2020.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
B. C. M. Stephan, Birdi, R., Tang, E. Yee Hing, Cosco, T. D., Donini, L. M., Licher, S., M Ikram, A., Siervo, M., and Robinson, L., “Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 2, pp. 653-680, 2018.

Pages